ONCOPEP
OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The company's proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute. The technology, which OncoPep has exclusively licensed from Dana Farber, employs a unique combination of proprietary peptides to form a therapeutic cancer vaccine. Vaccines developed from this technology are designed to stimulate the patient’s immune system to attack his or her cancer through an optimized combination of disease-specific peptides and adjuvants (substances that stimulate the immune system).
ONCOPEP
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
North Andover, Massachusetts, United States
Country:
United States
Website Url:
http://www.oncopep.com
Total Employee:
1+
Status:
Active
Contact:
+1 978 837 1129
Email Addresses:
[email protected]
Total Funding:
28.44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Global Site Tag
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Pyxis Oncology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Investors List
Crystal Bioscience
Crystal Bioscience investment in Series D - OncoPep
Kukje Pharma
Kukje Pharma investment in Series D - OncoPep
Tera Science
Tera Science investment in Series D - OncoPep
Leukemia & Lymphoma Society
Leukemia & Lymphoma Society investment in Series B - OncoPep
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-17 | Dr. Victor Moyo, MBChB, Joins OncoPep as Chief Medical Officer |
Official Site Inspections
http://www.oncopep.com Semrush global rank: 5.8 M Semrush visits lastest month: 1.44 K
- Host name: 72.65.245.35.bc.googleusercontent.com
- IP address: 35.245.65.72
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "OncoPep"
OncoPep - Crunchbase Company Profile & Funding
OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The company's …See details»
Overview - About Us - OncoPep
OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company’s proprietary core technology was …See details»
OncoPep 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for OncoPep. Use the PitchBook Platform to explore the full profile.See details»
OncoPep Company Profile - Office Locations, Competitors ... - Craft
May 17, 2022 OncoPep has 1 employees at their 1 location and $6.9 m in total funding,. See insights on OncoPep including office locations, competitors, revenue, financials, executives, …See details»
OncoPep, Inc. Company Profile | Cambridge, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for OncoPep, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
OncoPep - Funding, Financials, Valuation & Investors
OncoPep is a developer of a multi-peptide therapeutic vaccine to prevent the progression of cancer.See details»
OncoPep - Company Profile - Tracxn
Feb 8, 2025 OncoPep - Targeted immunotherapeutics (vaccines) against cancer. Raised a total funding of $20.4M over 3 rounds from 7 investors.See details»
OncoPep, Inc. Overview | SignalHire Company Profile
OncoPep, Inc. is a private company that has been in the industry for 14 years. The company currently specializes in the Biotechnology area. The position of the CEO is occupied by Doris …See details»
OncoPep - Org Chart, Teams, Culture & Jobs | The Org
View OncoPep's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Organization | OncoPep, Inc. - Purdue University
OncoPep, Inc. Report issue For profit Phase 1 Phase 2 Founded: North Andover MA United States (2010) Organization Overview First Clinical TrialSee details»
OncoPEP - Products, Competitors, Financials, Employees, …
OncoPEP is a biotechnology company focused on the development of immunotherapeutics for cancer treatment. The company offers investigational cancer vaccines and cell therapies …See details»
OncoPep
OncoPep Presents Updated Results of a Phase 1/2a Clinical Trial with Multi-Peptide Vaccine to Treat Smoldering Multiple Myeloma 12-07-2015 OncoPep Raises $6.9 Million Series B …See details»
OncoPep, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore OncoPep, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 1 news, and 2 literature, Disease Domain:Neoplasms, Immune ...See details»
OncoPep - VentureRadar
OncoPep is developing targeted immunotherapeutics to prevent the progression of cancer, prolong survival and restore the quality of life of patients. OncoPep™s lead program is a multi …See details»
OncoPep Company Information - Funding, Investors, and More
OncoPep is a company developing immunotherapeutics for thetreatment of cancer founded in 2010 by Doris Peterkin, Ken Anderson and Marc Cohen.See details»
OncoPep - Contacts, Employees, Board Members, Advisors & Alumni
OncoPep is a developer of a multi-peptide therapeutic vaccine to prevent the progression of cancer.See details»
OncoPep - Overview, News & Similar companies | ZoomInfo.com
View OncoPep (www.oncopep.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
OncoPep Completes $11 Million Series D Financing to Continue …
Cambridge, MA – December 09, 2021 – OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by …See details»
OncoPep | VentureRadar
OncoPep is developing targeted immunotherapeutics to prevent the progression of cancer, prolong survival and restore the quality of life of patients. OncoPep™s lead program is a multi …See details»
Resources - OncoPep, Inc.
Lenalidomide polarizes Th1 specific anti-tumor response and expands XBP-1 antigen-specific central memory CD3+CD8+ T cells against various solid tumors.See details»